AC IMMUNE SA
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.22
-6.33%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-21.0%
3 months
+0.0%
6 months
-25.5%
1 year
-34.3%
Year to date
-29.3%
52-week range
$2.12 – $3.70
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$225.9M
P/E
-4.2
P/B
5.2
P/S
10.5
Revenue
$17.51M
Net income
-$43.16M
Diluted EPS
-0.43
Gross margin
100.00%
Net margin
-246.50%
Return on equity
-99.20%
Total debt
$4.1M
Cash
$27.76M
Free cash flow
-$52.66M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $15.11M | $1.87M | 100.00% | 12.40% | — |
| Mar 31, 2026 | $1.12M | -$14.8M | 100.00% | -1322.70% | — |
| Dec 31, 2025 | $338K | -$14.37M | 100.00% | -4252.40% | -$16.84M |
| Sep 30, 2025 | $939K | -$15.86M | 100.00% | -1688.80% | -$18.74M |
| Jun 30, 2025 | $1.31M | -$21.19M | 100.00% | -1622.40% | -$16.56M |
| Mar 31, 2025 | $990K | -$19.03M | 100.00% | -1922.10% | -$19.72M |
| Dec 31, 2024 | $1.14M | -$15.8M | 100.00% | -1389.40% | $5.42M |
| Sep 30, 2024 | $25.49M | $5.5M | 100.00% | 21.60% | -$14.64M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ACIU news
All market newsNo ticker-linked stories are in the current archive.